Page 489 - Clinical Application of Mechanical Ventilation
P. 489

Pharmacotherapy for Mechanical Ventilation  455


                          2. A  patient  who  has  been  using  Theo-Dur  at  home  states  that  she  experiences  palpitations,  nausea,
                            vomiting, headache, and agitation each time after taking the medication. The proper management
                            technique for this patient includes monitoring of the _______ level and titrating the dosage to a thera-
                            peutic range of _______.

                                   A.  serum theophylline, 5–15 mcg/mL   C.  serum theophylline, 40–60 mcg/mL
                                   B.  corticosteroid, 5–15 mcg/mL      D. corticosteroid, 40–60 mcg/mL


                          3. An asthmatic patient who has been using Ventolin for several months complains of shortness of breath
                            and states that “the Ventolin is not working any more.” The physician asks a therapist for suggestion.
                            The therapist should recommend a trial use of:

                                   A.  Proventil.                    C.  Brethine.
                                   B.  Alupent.                      D. Vanceril.


                          4. Which of the following is not an indication for using a neuromuscular blocking agent?
                                   A.  relieve laryngeal spasm       C.  facilitate endotracheal suctioning
                                   B.  maintain mechanical ventilation   D. enhance endotracheal intubation

                          5. Succinylcholine (Anectine, Quelicin) is a _______ neuromuscular blocking agent. It induces muscle
                            blockade by _______.

                                   A.  depolarizing, binding to the receptor sites and causing sustained depolarization
                                   B.  nondepolarizing, binding to the receptor sites and causing sustained depolarization
                                   C.  depolarizing, competing for the receptor sites and blocking the action of acetylcholine
                                   D. nondepolarizing, competing for the receptor sites and blocking the action of acetylcholine

                          6. All of the following are potential complications of a neuromuscular blocking agent except :
                                   A.  oversedation.                 C.  apnea.
                                   B.  prolonged muscle blockade.    D. bronchospasm.


                          7. A patient who has been given Norcuron one hour ago is recovering in the surgical intensive care unit. The
                            physician wants to know whether neuromuscular blockade reversal has occurred. The therapist should
                            check all of the following except:

                                   A.  tongue protusion.             C.  hand grip.
                                   B.  serum acetylcholine level.    D. head lift.


                          8. A  mechanically  ventilated  patient  has  been  receiving  diazepam  (Valium)  for  better  tolerance  of
                            mechanical ventilation and related procedures. The cardiovascular adverse effects for his patient may
                            include:
                                   A.  decreased cardiac output.     C.  increased mean arterial pressure.
                                   B.  increased stroke volume.      D. increased systemic vascular resistance.


                          9. The Ramsay Scale is commonly used to assess the degree of:
                                   A.  ventilation.                  C.  bronchodilation.
                                   B.  pain.                         D. sedation.






                        Copyright 2013 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
                      Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
   484   485   486   487   488   489   490   491   492   493   494